Aiello, Edoardo Nicolò
Verde, Federico https://orcid.org/0000-0002-3977-6995
Curti, Beatrice
De Luca, Giulia
Diana, Lorenzo
Sirtori, Martina Andrea
Maranzano, Alessio
Curatoli, Chiara
Zanin, Alice
Camporeale, Elisa
Gnesa, Alessandra
Silani, Vincenzo
Bolognini, Nadia
Ticozzi, Nicola
Poletti, Barbara
Funding for this research was provided by:
Ministero della Salute (Ministero della Salute)
Article History
Received: 24 August 2024
Accepted: 16 December 2024
First Online: 8 January 2025
Declarations
:
: Participants provided informed consent. This study was approved by the Ethics Committee of IRCCS IstitutoAuxologico Italiano (I.D.: 23C125, 25C122, 23C308).
: F.V. is Associate Editor of Journal of Alzheimer’s Disease. V.S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG, Amylyx Pharmaceuticals, Biogen, and Zambon Biotech SA; he receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call; he is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Disease, Frontiers in Neurology, and Exploration of Neuroprotective Therapy. N.T. received compensation for consulting services and/or speaking fees from Amylyx Pharmaceuticals, Biogen, Italfarmaco, and Zambon Biotech SA; he is Associate Editor for Frontiers in Aging Neuroscience. B.P. is Associate Editor for Frontiers in Neuroscience; she received compensation for consulting services and/or speaking activities from Liquidweb S.r.l.